Schedule 13D ownership disclosure

HILLEVAX INC

Common Stock, par value $0.0001 per share · CUSIP: 43157M102

Event date: 2025-05-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 4,920,000.00 · Class: 9.8%

  • KEVIN TANGReported CIK 0001178579

    Shares: 4,920,000.00 · Class: 9.8%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 2,767,008.00 · Class: 5.5%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LPReported CIK 0002064011

    Shares: 2,152,992.00 · Class: 4.3%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-006873
Form type
SCHEDULE 13D
Filer
HilleVax, Inc.
CIK
CIK 1888012
Filed
May 02, 2025
Reporting period
May 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub